Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for KORU Medical Systems, Inc. (KRMD : NSDQ)

• Company Description    KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J. Number of Employees: 80

• Price / Volume Information    Yesterday's Closing Price: $6.23 Daily Weekly Monthly 20 Day Moving Average: 192,097 shares Shares Outstanding: 46.32 (millions) Market Capitalization: $288.59 (millions) Beta: 0.58 52 Week High: $6.61 52 Week Low: $1.86 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 7.41% 5.60% 12 Week 64.82% 59.71% Year To Date 61.82% 42.81%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 100 CORPORATE DRIVE - MAHWAH,NJ 07430 USA ph: 845-469-2042 fax: 845-469-5518 investor@korumedical.com http://www.korumedical.com

• General Corporate Information    Officers Linda Tharby - President and Chief Executive Officer R. John Fletcher - Chairman Thomas Adams - Chief Financial Officer and Treasurer Edward Wholihan - Director Robert A. Casella - Director Peer Information KORU Medical Systems, Inc. (HLIS) KORU Medical Systems, Inc. (AZTA) KORU Medical Systems, Inc. (APYI) KORU Medical Systems, Inc. (RNVA) KORU Medical Systems, Inc. (HMSY) KORU Medical Systems, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 759910102 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/11/26 Share - Related Items Shares Outstanding: 46.32 Most Recent Split Date: (:1) Beta: 0.58 Market Capitalization: $288.59 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.02 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.06 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 17.49 Price/Cash Flow: - Price / Sales: 7.39 EPS Growth vs. Year Ago Period: 33.33% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 27.16% vs. Previous Quarter: 2.03% ROE 09/30/25 - -22.43 06/30/25 - -26.77 03/31/25 - -30.43 ROA 09/30/25 - -13.86 06/30/25 - -16.81 03/31/25 - -19.41 Current Ratio 09/30/25 - 2.48 06/30/25 - 2.91 03/31/25 - 2.44 Quick Ratio 09/30/25 - 1.92 06/30/25 - 2.25 03/31/25 - 2.02 Operating Margin 09/30/25 - -9.49 06/30/25 - -12.24 03/31/25 - -15.09 Net Margin 09/30/25 - -9.49 06/30/25 - -12.24 03/31/25 - -15.09 Pre-Tax Margin 09/30/25 - -9.45 06/30/25 - -12.20 03/31/25 - -15.09 Book Value 09/30/25 - 0.36 06/30/25 - 0.36 03/31/25 - 0.35 Inventory Turnover 09/30/25 - 4.08 06/30/25 - 3.89 03/31/25 - 4.07 Debt-to-Equity 09/30/25 - 0.01 06/30/25 - 0.01 03/31/25 - 0.01 Debt-to-Capital 09/30/25 - 0.70 06/30/25 - 0.87 03/31/25 - 1.05

Powered by Zacks Investment Research ©